Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group
Authors:
- Arnab ChakravartiACArnab Chakravarti
- Kathryn WinterKWKathryn Winter
- Chin-Lee WuCWChin-Lee Wu
- Donald KaufmanDKDonald Kaufman
- Elizabeth HammondEHElizabeth Hammond
- Matthew ParliamentMPMatthew Parliament
- William TesterWTWilliam Tester
- Michael HaganMHMichael Hagan
- David GrignonDGDavid Grignon
- Niall HeneyNHNiall Heney
- Alan PollackAPAlan Pollack
- Howard SandlerHSHoward Sandler
- 1 June 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 62 (2) , 309-317
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal of Cancer, 2001
- Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cellsExperimental Hematology, 2001
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000
- TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivoGene Therapy, 2000
- Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer CellsJournal of Biological Chemistry, 1999
- Transforming growth factor ? (TGF-?) expression in dysplastic oral leukoplakia: Modulation by 13-cis retinoic acidHead & Neck, 1999
- Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ proteinNature, 1999
- Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cellsProceedings of the National Academy of Sciences, 1998
- Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cellsOncogene, 1997
- The epidermal growth factor receptor as a target for therapy in breast carcinomaBreast Cancer Research and Treatment, 1994